| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.18 |
5e-05 |
| mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-05 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0002 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |